Evonik Invests USD 100 Million to Expand US Drug Manufacturing
Evonik is investing USD 100 million to upgrade its US drug substance Contract Development and Manufacturing (CDMO) facility, expanding manufacturing capacity to meet growing demand for US-based pharmaceutical outsourcing.
Active Pharmaceutical Ingredient (API) | 10/07/2026 | By News Bureau
Ocuvex Resubmits CRL to FDA for PDP-716 NDA, SPARC Reveals
Sun Pharma Advanced Research Company (SPARC) announced that Ocuvex Therapeutics has resubmitted a Complete Response Letter (CRL) to the US Food and Drug Administration (FDA) for the New Drug Application (NDA) of PDP-716.
Active Pharmaceutical Ingredient (API) | 20/11/2025 | By Dineshwori | 486
Lilly to Establish USD 5 Billion API Manufacturing Facility in Virginia
The new site in Virginia marks the first of four new US manufacturing sites that Lilly plans to announce this year.
Active Pharmaceutical Ingredient (API) | 17/09/2025 | By Dineshwori | 203
Dr Reddy's UK API Facility Receives Seven FDA Observations Following Inspection
Dr Reddy’s Laboratories has announced that its Active Pharmaceutical Ingredient (API) manufacturing facility in Mirfield, West Yorkshire, United Kingdom, has come under scrutiny from the United States Food and Drug Administration (FDA).
Active Pharmaceutical Ingredient (API) | 08/09/2025 | By Darshana | 641
Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
Active Pharmaceutical Ingredient (API) | 25/08/2025 | By Dineshwori | 236
The global demand for 2-Methylpiperazine is growing significantly due to its wide applicability in pharmaceutical formulations and specialty chemical development, according to a new study by Polaris Market Research.
Active Pharmaceutical Ingredient (API) | 12/08/2025 | By Dineshwori | 255
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy